TY  - GEN
AU  - Konecny,Gottfried E
AU  - Finkler,Neil
AU  - Garcia,Agustin A
AU  - Lorusso,Domenica
AU  - Lee,Paula S
AU  - Rocconi,Rodney P
AU  - Fong,Peter C
AU  - Squires,Matt
AU  - Mishra,Kaushal
AU  - Upalawanna,Allison
AU  - Wang,Yongyu
AU  - Kristeleit,Rebecca
TI  - Second-line dovitinib (TKI258) in patients with FGFR2-mutated or FGFR2-non-mutated advanced or metastatic endometrial cancer: a non-randomised, open-label, two-group, two-stage, phase 2 study
SN  - 1474-5488
PY  - 2015///0831
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Benzimidazoles
KW  - administration & dosage
KW  - Disease-Free Survival
KW  - Endometrial Neoplasms
KW  - drug therapy
KW  - Female
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Middle Aged
KW  - Mutation
KW  - Neoplasm Metastasis
KW  - Neoplasm Staging
KW  - Quinolones
KW  - Receptor, Fibroblast Growth Factor, Type 2
KW  - genetics
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/S1470-2045(15)70159-2
ER  -